Addition of PD-1/PD-L1 inhibitors to chemotherapy for triple-negative breast cancer: a meta-analysis.

Front Oncol · 2024 · PMC10884307 · PMID 38406799

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

The exploratory results revealed a clear trend toward improved outcomes (including PFS and OS) with PD-L1 enrichment.

also in 19,460 other papers

an increasing trendno p-value reported

The results indicated an increasing trend in OS with PD-L1 enrichment.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.